This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Prevention of rebleeding

Authoring team

Around half of people who survive an aneurysmal subarachnoid haemorrhage will have a second bleed from the culprit aneurysm within weeks, and the mortality from a second bleed can exceed 50%

NICE note:

  • an interventional neuroradiologist and a neurosurgeon should discuss the options for managing the culprit aneurysm, taking into account the person's clinical condition, the characteristics of the aneurysm, and the amount and location of subarachnoid blood. Options include:
    • endovascular coiling
      • endovascular coiling is less invasive and potentially safer
        • should be offered as the first option, taking factors such as aneurysm characteristics and the amount and location of subarachnoid blood into account
    • neurosurgical clipping
    • no interventional procedure, with monitoring to check for clinical improvement and reassess the options for treatment

  • if interventional treatment is planned, ensure that it is carried out at the earliest opportunity to prevent rebleeding
    • be aware that the risk of rebleeding is highest within 24 hours of the onset of symptoms.

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.